ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Oncolytics Biotech Inc. 

210-1167 Kensington Crescent

Calgary  Alberta  T2N 1X7  Canada
Phone: 403-670-7374 Fax: 403-283-0858


SEARCH JOBS


Industry
Biotechnology






 Company News
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Head And Neck Cancer Biomarker Preclinical Research At UK Oncolytic Virus Conference 4/14/2014 6:58:47 AM    More...
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Translational Brain Cancer Clinical Data And Immunomodulatory Preclinical Research At UK Oncolytic Virus Conference 4/11/2014 6:54:48 AM    More...
Oncolytics Biotech Inc. (ONC.TO) Announces Additional Data From REO 018 Randomized Study Of REOLYSIN® In Head And Neck Cancers 4/8/2014 8:54:20 AM    More...
Oncolytics Biotech Inc. (ONC.TO) Collaborators To Present Preclinical Research In Multiple Myeloma And Melanoma At American Association for Cancer Research 2014 Annual Meeting 4/7/2014 6:44:42 AM    More...
Oncolytics Biotech Inc. (ONC.TO) Announces 2013 Year End Results 3/13/2014 6:25:25 AM    More...
Oncolytics Biotech Inc. (ONC.TO) Announces Initial $1.0 Million Investment And Up To $25.0 Million Common Share Purchase Agreement With Lincoln Park Capital Fund, LLC 2/27/2014 10:24:37 AM    More...
Media Advisory - Oncolytics Biotech Inc. (ONC.TO) To Participate In 2014 RBC Capital Markets Global Healthcare Conference 2/25/2014 6:21:03 AM    More...
Oncolytics Biotech Inc. (ONC.TO) To Present At The 25th Annual Piper Jaffray Healthcare Conference 12/3/2013 9:24:07 AM    More...
Oncolytics Biotech Inc. (ONC.TO) Calls Cancer-Fighting Virus Study "Positive" But Results Are Unconvincing 11/22/2013 8:54:09 AM    More...
Oncolytics Biotech Inc. (ONC.TO) Announces Positive Top-Line Data From REO 018 Randomized Study Of REOLYSIN® In Head And Neck Cancers 11/21/2013 11:07:57 AM    More...
12345678910...